Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

NCT05480449 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

89

Enrollment

OTHER

Sponsor class

Conditions

B Cell Acute Lymphoblastic Leukemia (B-ALL)
B Lineage Lymphoblastic Lymphoma

Interventions

BIOLOGICAL: Autologous Humanized CD19-Directed Chimeric Antigen Receptor T-Cells (huCART19)

Sponsor

Stephan Grupp MD PhD

Collaborators

[object Object]